Silverman E S, Khachigian L M, Lindner V, Williams A J, Collins T
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Am J Physiol. 1997 Sep;273(3 Pt 2):H1415-26. doi: 10.1152/ajpheart.1997.273.3.H1415.
Platelet-derived growth factor (PDGF) A-chain is expressed by vascular smooth muscle cells (SMC) in a variety of pathological settings. Phorbol 12-myristate 13-acetate (PMA) increases A-chain transcription and was used as a model agonist. Transient transfection analysis identified a region in the promoter that is required for inducibility, located between base pairs -71 and -55 from the transcription start site. This region contains overlapping recognition elements for members of the Sp and Egr families. Egr-1 transcript and protein increased after PMA treatment, whereas Sp1 and Sp3 levels remain unchanged. Egr-1 expression and PDGF A-chain promoter activity also increased in cells exposed to PDGF or mechanical injury. In vitro binding assays demonstrated that Egr-1, Sp1, and Sp3 can bind to this promoter region and that increasing Egr-1 can displace both Sp1 and Sp3. In an in vivo model of arterial injury, Egr-1 expression was induced concurrently with the expression of PDGF-A in SMC. Displacement of Sp1 and Sp3 by Egr-1 is correlated with inducible PDGF A-chain expression in the vessel wall.
血小板衍生生长因子(PDGF)A链在多种病理情况下由血管平滑肌细胞(SMC)表达。佛波酯12-肉豆蔻酸酯13-乙酸酯(PMA)可增加A链转录,并被用作模型激动剂。瞬时转染分析确定了启动子中一个诱导性所必需的区域,位于转录起始位点的碱基对-71至-55之间。该区域包含Sp和Egr家族成员的重叠识别元件。PMA处理后,Egr-1转录本和蛋白质增加,而Sp1和Sp3水平保持不变。在暴露于PDGF或机械损伤的细胞中,Egr-1表达和PDGF A链启动子活性也增加。体外结合试验表明,Egr-1、Sp1和Sp3可结合至该启动子区域,增加Egr-1可取代Sp1和Sp3。在动脉损伤的体内模型中,SMC中Egr-1表达与PDGF-A表达同时被诱导。Egr-1取代Sp1和Sp3与血管壁中可诱导的PDGF A链表达相关。